Sanofi Group Chief Executive Officer Christopher A. Viehbacher has announced the French-based global pharmaceutical producer’s plans to build its third factory in HCM City’s high technology park during a press conference on March 29.

The new state-of-the-art plant will expand Sanofi’s manufacturing capacity in Vietnam to meet the Vietnamese pharmaceutical market’s surging demand as well as serve as an export platform to other ASEAN countries.

The US$75 million to be invested in the new plant represents Sanofi’s largest investment in Vietnam to date.

With an initial output capacity of 90 million units per year—and a possible extension of up to 150 million units—the facility will produce high-quality pharmaceuticals and consumer healthcare products.

The plant is scheduled to be fully operational by the end of 2015, joining Sanofi’s existing emerging market network comprised of 40 manufacturing sites.

“This new production and development centre is the largest investment ever made by Sanofi in Vietnam and illustrates our commitment to bringing high quality medicines to a broader population in Vietnam”, said Viehbacher.

“Sanofi has operated in Vietnam for more than 50 years and secured a market-leading position in one of the most dynamic South East Asian countries. This new investment will contribute to further strengthening Sanofi’s leadership in emerging markets,” he added.

Source: VOV